Skip to main content
Veterinary Medicines

BUTASYL 1 mg/ml + 50 mg/ml SOLUCION INYECTABLE

Authorised
  • Phenylbutazone
  • Sodium salicylate

Product identification

Medicine name:
BUTASYL 1 mg/ml + 50 mg/ml SOLUCION INYECTABLE
Active substance:
  • Phenylbutazone
  • Sodium salicylate
Target species:
  • Horse (non food-producing)
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Phenylbutazone
    1861.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium salicylate
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Horse (non food-producing)
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01BX
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Spain S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • Spanish Agency For Medicines And Medical Devices
Authorisation number:
  • 2101 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 13/09/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 23/10/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 23/10/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."